WHO accepts Bharat Biotech's Expression of Interest for Covaxin emergency use listing

Credit: IndiaTimes- Published on June 17, 2021
The World Health Organisation (WHO) has accepted Bharat Biotech’s expression of interest (EoI) for the emergency use listing (EUL) of India's first indigenously developed Covid-19 vaccine Covaxin after the company provided the additional data that was sought by the global body. The pharmaceutical company's pre-submission...

You are here

💡 newsR Knowledge: Other News Mentions


Vaccine against COVID-19
After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
Credit: IndiaTimes - Published 10 hours ago

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
Credit: IndiaTimes - Published 2 days ago

In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
Credit: DNA - Published 5 days ago

Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation..
Credit: IndiaTimes - Published 5 days ago

World Health Organization

Specialized agency of the United Nations
The head of the World Health Organisation has branded electronic cigarettes "harmful" as he warned their use should be better regulated to protect children and..
1 day ago • Sky News
China has shut down a city of 9.3 million people over 17 COVID-19 infections, while a proposed second phase of a World Health Organization (WHO) investigation..
1 week ago • Sky News


Disease caused by severe acute respiratory syndrome coronavirus 2
A 61-year-old Delhi doctor is the first proven case to have suffered from three Covid infections — two of these SARS-CoV-2 bouts were caused by its Alpha and..
Credit: IndiaTimes - Published 37 minutes ago

With the Covid pandemic delaying crucial missions of Isro, the country’s third lunar mission Chandrayaan-3 is now “likely to be launched during the third..
Credit: IndiaTimes - Published 1 hour ago

Credit: IndiaTimes - Published 3 hours ago

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Credit: IndiaTimes - Published 1 day ago

Related videos from verified sources

Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News 02:13
Credit: Oneindia - Published on July 3, 2021 

Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens | Oneindia News 02:09
Credit: Oneindia - Published on July 1, 2021 

Covaxin neutralizes both Alpha & Delta variants of coronavirus: US Institute| Oneindia News 02:11
Credit: Oneindia - Published on June 30, 2021 

Related news from verified sources

The World Health Organisation (WHO) has accepted Bharat Biotech’s expression of interest (EoI) for the emergency use listing (EUL) of India's first...
on June 17, 2021 • IndiaTimes

Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of...
on June 17, 2021 • IndiaTimes

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use...
on June 17, 2021 • IndiaTimes

You might like